1. Proteomic biomarkers in lung cancer

   • M. D. Pastor
   • A. Nogal
   • L. Paz-Ares

   Educational Series - Blue Series 20 April 2013 Pages: 671 - 682

2. Research opportunities in intraoperative radiation therapy: the next decade 2013–2023

   • F. A. Calvo
   • C. V. Sole
   • C. Ferrer

   EDUCATIONAL SERIES–RED SERIES 05 March 2013 Pages: 683 - 690

   

3. Clinical and prognostic usefulness of serum proteomic profile in hepatic colorectal metastases: a pilot prospective study

   • J. Martí
   • J. Fuster
   • J. C. García-Valdecasas

   Research Article 30 January 2013 Pages: 691 - 697

   

4. Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

   • J. P. Maroto
   • X. G. del Muro
   • J. A. Meana

   Research Article 29 January 2013 Pages: 698 - 704

   

5. Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer

   • A. Carrato
   • A. Gómez
   • E. Aranda

   Research Article 29 January 2013 Pages: 705 - 711

   

6. Carnosol, radiation and melanoma: a translational possibility

   • M. Alcaraz
   • D. G. Achel
   • J. Castillo

   Research Article 29 January 2013 Pages: 712 - 719

   

7. Beam angle selection for intensity-modulated radiotherapy (IMRT) treatment of unresectable pancreatic cancer: are noncoplanar beam angles necessary?

   • D. S. Chang
   • G. K. Bartlett
   • H. R. Cardenes

   Research Article 29 January 2013 Pages: 720 - 724

   

8. Management of malignant insulinoma

   • J. C. Ferrer-García
   • V. Iranzo González-Cruz
   • C. Camps Herrero

   Research Article 05 March 2013 Pages: 725 - 731

9. Defining prognostic factors of survival after external beam radiotherapy treatment of hepatocellular carcinoma with lymph node metastases

   • Y.-X. Chen
   • Z.-C. Zeng
   • J. Sun

   Research Article 05 February 2013 Pages: 732 - 740

   

10. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression

    • P. Liu
    • H. Liang
    • Z. Tu

    Research Article 29 January 2013 Pages: 741 - 746

    

11. Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung

    • B. Jeremić
    • B. Miličić
    • S. Milisavljević

    Research Article 29 January 2013 Pages: 747 - 753

12. Clinical target volume definition for glioblastoma radiotherapy planning: magnetic resonance imaging and computed tomography

    • A. Fiorentino
    • R. Caivano
    • V. Fusco

    Brief Research Article 29 January 2013 Pages: 754 - 758